Curanex Pharmaceuticals Inc (CURX) — Institutional Holders, Q2 2026
11 institutional investment managers reported a CURX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $89.0K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
CURX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- RENAISSANCE TECHNOLOGIESNew · +52,000 sh+$13.8K
- Virtu FinancialNew · +51,236 sh+$13.6K
- CITADEL ADVISORSAdded · +44,699 sh+$11.9K
- JANE STREET GROUPNew · +31,215 sh+$8.3K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPNew · +14,657 sh+$3.9K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -72,842 sh-$19.3K
- TWO SIGMA SECURITIESSold out · -56,651 sh-$15.0K
- XTX Topco LtdSold out · -51,289 sh-$13.6K
- Jump FinancialSold out · -10,551 sh-$2.8K
- CITIGROUPTrimmed · -10,375 sh-$2.8K
CURX 13F holders ranked 1–11 of 11
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS#1 · 95,258 sh | 95,258 | $25.3K | 0.00% | +88.4% |
| 2 | Virtu Financial#2 · 51,236 sh | 51,236 | $14.0K | <0.01% | New |
| 3 | RENAISSANCE TECHNOLOGIES#3 · 52,000 sh | 52,000 | $13.8K | 0.00% | New |
| 4 | GEODE CAPITAL MANAGEMENT#4 · 38,288 sh | 38,288 | $10.2K | 0.00% | -65.5% |
| 5 | JANE STREET GROUP#5 · 31,215 sh | 31,215 | $8.3K | 0.00% | New |
| 6 | TWO SIGMA INVESTMENTS#6 · 27,354 sh | 27,354 | $7.3K | 0.00% | +35.1% |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#7 · 14,657 sh | 14,657 | $3.9K | 0.00% | New |
| 8 | Ground Swell Capital#8 · 12,638 sh | 12,638 | $3.4K | <0.01% | New |
| 9 | CITIGROUP#9 · 8,957 sh | 8,957 | $2.4K | 0.00% | -53.7% |
| 10 | UBS Group AG#10 · 1,506 sh | 1,506 | $400.00 | 0.00% | -81.2% |
| 11 | Tower Research Capital (TRC)#11 · 1,000 sh | 1,000 | $265.00 | 0.00% | New |
Funds that sold out of CURX in Q2 2026 (3)
Held CURX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| TWO SIGMA SECURITIES56,651 sh | 56,651 | $29.0K |
| XTX Topco Ltd51,289 sh | 51,289 | $26.2K |
| Jump Financial10,551 sh | 10,551 | $5.4K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.